pharma · Epilepsy · Attention-Deficit/Hyperactivity Disorder (ADHD) · SUPN
SUPERNUS PHARMACEUTICALS
SUPERNUS PHARMACEUTICALS, INC.
SUPERNUS PHARMACEUTICALS clinical programs — 23 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 9715 Key West Ave, Rockville, Maryland 20850, US
- Founded
- 2005
- Employees
- 828
- Programs
- 55
- Drugs
- 25
- Patents
- 68
SUPERNUS PHARMACEUTICALS projects
23 ClinicalTrials.gov programs sponsored by SUPERNUS PHARMACEUTICALS.
SUPERNUS PHARMACEUTICALS has 23 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
817P203
SUPERNUS PHARMACEUTICALS, INC.
Focal Onset Seizures
1 trial -
BIS-001ER
SUPERNUS PHARMACEUTICALS, INC.
Focal Impaired Awareness Seizures
1 trial -
Botulinum Toxin Type B (Myobloc)
SUPERNUS PHARMACEUTICALS, INC.
Drooling
1 trial -
Brexanolone
SUPERNUS PHARMACEUTICALS, INC.
Tinnitus
1 trial -
Gocovri (extended-release amantidine)
SUPERNUS PHARMACEUTICALS, INC.
Radiation Encephalopathy
1 trial -
IR Viloxazine
SUPERNUS PHARMACEUTICALS, INC.
Attention-Deficit/Hyperactivity Disorder (ADHD)
1 trial -
IR-TPM (Topamax)
SUPERNUS PHARMACEUTICALS, INC.
Migraine
1 trial -
Molindone
SUPERNUS PHARMACEUTICALS, INC.
Impulsive Aggression Comorbid With ADHD in Children
1 trial -
NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Major Depressive Disorder
1 trial -
NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Treatment Resistant Depression
1 trial -
SAGE-547
SUPERNUS PHARMACEUTICALS, INC.
Severe Postpartum Depression
1 trial -
SAGE-547
SUPERNUS PHARMACEUTICALS, INC.
Postpartum Depression
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Alzheimer Disease
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Huntington Disease
2 trials -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Mild Cognitive Impairment
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Parkinson Disease
1 trial -
SAGE-718-matching placebo
SUPERNUS PHARMACEUTICALS, INC.
Parkinson Disease
1 trial -
SPN-810
SUPERNUS PHARMACEUTICALS, INC.
Attention Deficit Disorder With Hyperactivity
1 trial -
SPN-810
SUPERNUS PHARMACEUTICALS, INC.
Impulsive Aggression Comorbid With ADHD
1 trial -
SPN-817
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial -
SPN-817
SUPERNUS PHARMACEUTICALS, INC.
Focal Onset Seizures
2 trials -
SPN-821 2400 mg
SUPERNUS PHARMACEUTICALS, INC.
Major Depressive Disorder (MDD)
1 trial -
TPM XR
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial
Frequently asked questions
How many clinical projects does SUPERNUS PHARMACEUTICALS have?
23 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.